Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Synaptic and Merck & Co. prepare selective human alpha1A-adrenoceptor antagonists

July 7, 1997

Shire acquires distribution rights for Urispas from Recordati

July 2, 1997

Joint venture formed to market RenaGel

June 19, 1997

RPR seeks FDA approval for DDAVP tablets for bed-wetting

June 19, 1997

Compounds for urinary incontinence from Kyowa Hakko

June 17, 1997

Multinational trial assesses efficacy and safety of tolterodine for incontinence

June 9, 1997

Tamsulosin cleared by FDA

May 27, 1997

Mouse model for idiopathic voiding disorders in humans

May 15, 1997

Endothelin antagonists described by Takeda

May 14, 1997

Preclinical and clinical profile of Pharmacia & Upjohn's tolterodine

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...